{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:26:29Z","timestamp":1787750789833,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes & Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/s2213-8587(22)00277-7","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T18:40:08Z","timestamp":1667846408000},"page":"859-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":186,"title":["Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period"],"prefix":"10.1016","volume":"10","author":[{"given":"Andrea M","family":"Haqq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Dollfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Haws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel \u00c1","family":"Martos-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Poitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A","family":"Yanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Mittleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Forsythe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Argente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00277-7_bib1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.biopsych.2022.01.018","article-title":"Monogenic obesity syndromes provide insights into the hypothalamic regulation of appetite and associated behaviors","volume":"91","author":"Farooqi","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2213-8587(22)00277-7_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fped.2018.00023","article-title":"Managing Bardet-Biedl syndrome\u2014now and in the future","volume":"6","author":"Forsythe","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/S2213-8587(22)00277-7_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jmg.36.6.437","article-title":"New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey","volume":"36","author":"Beales","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(22)00277-7_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12703","article-title":"Bardet-Biedl syndrome: weight patterns and genetics in a rare obesity syndrome","volume":"16","author":"Pomeroy","year":"2021","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(22)00277-7_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100780","article-title":"The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alstr\u00f6m syndrome: phase 3 trial design","volume":"22","author":"Haws","year":"2021","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/S2213-8587(22)00277-7_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1001\/jama.289.14.1813","article-title":"Health-related quality of life of severely obese children and adolescents","volume":"289","author":"Schwimmer","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00277-7_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrendo.2010.210","article-title":"Alstr\u00f6m syndrome: insights into the pathogenesis of metabolic disorders","volume":"7","author":"Girard","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00277-7_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cge.13367","article-title":"Clinical, molecular genetics and therapeutic aspects of syndromic obesity","volume":"95","author":"Geets","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/S2213-8587(22)00277-7_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajhg.2015.04.023","article-title":"Copy-number variation contributes to the mutational load of Bardet-Biedl syndrome","volume":"99","author":"Lindstrand","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(22)00277-7_bib10","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41436-020-0761-1","article-title":"The morbid genome of ciliopathies: an update","volume":"22","author":"Shamseldin","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(22)00277-7_bib11","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/db18-1088","article-title":"The BBSome in POMC and AgRP neurons is necessary for body weight regulation and sorting of metabolic receptors","volume":"68","author":"Guo","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00277-7_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142064","article-title":"Melanocortin 4 receptor signals at the neuronal primary cilium to control food intake and body weight","volume":"131","author":"Wang","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(22)00277-7_bib13","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/dom.14133","article-title":"Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome","volume":"22","author":"Haws","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00277-7_bib14","doi-asserted-by":"crossref","first-page":"E528","DOI":"10.1210\/jc.2010-2290","article-title":"Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance","volume":"96","author":"Feuillan","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00277-7_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146287","article-title":"Bardet-Biedl syndrome proteins regulate intracellular signaling and neuronal function in patient-specific iPSC-derived neurons","volume":"131","author":"Wang","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(22)00277-7_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s42255-021-00345-3","article-title":"POMC neuronal heterogeneity in energy balance and beyond: an integrated view","volume":"3","author":"Quarta","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(22)00277-7_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2012.115","article-title":"Bardet-Biedl syndrome","volume":"21","author":"Forsythe","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(22)00277-7_bib18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cub.2007.08.034","article-title":"Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease","volume":"17","author":"Davenport","year":"2007","journal-title":"Curr Biol"},{"key":"10.1016\/S2213-8587(22)00277-7_bib19","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/sj.ejhg.5201933","article-title":"Alstr\u00f6m syndrome","volume":"15","author":"Marshall","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(22)00277-7_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00277-7_bib21","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2017.6803","article-title":"Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement","volume":"317","author":"Grossman","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00277-7_bib22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/0883073813495959","article-title":"Clinical trials in rare disease: challenges and opportunities","volume":"28","author":"Augustine","year":"2013","journal-title":"J Child Neurol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00277-7_bib23","first-page":"S1","article-title":"Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia","volume":"22","author":"Heymsfield","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(22)00277-7_bib24","author":"Ervin"},{"key":"10.1016\/S2213-8587(22)00277-7_bib25","author":"Forsythe"},{"key":"10.1016\/S2213-8587(22)00277-7_bib26","author":"Tchang"},{"key":"10.1016\/S2213-8587(22)00277-7_bib27","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00277-7_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","article-title":"MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency","volume":"24","author":"Cl\u00e9ment","year":"2018","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(22)00360-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000}}],"container-title":["The Lancet Diabetes & Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:59Z","timestamp":1761991919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213858722002777"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00277-7","relation":{},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00277-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00309-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}